Kunte, S.C.; Holzgreve, A.; Unterrainer, M.; Zahner, J.; Schmid, H.P.; Schöll, M.; Blajan, I.; Sheikh, G.T.; Mehrens, D.; Casuscelli, J.;
et al. Changes of Prostate-Specific Membrane Antigen-Radioligand Uptake on PET with Systemic Therapy in Patients with Metastatic Renal Cell Carcinoma. Cancers 2025, 17, 1736.
https://doi.org/10.3390/cancers17111736
AMA Style
Kunte SC, Holzgreve A, Unterrainer M, Zahner J, Schmid HP, Schöll M, Blajan I, Sheikh GT, Mehrens D, Casuscelli J,
et al. Changes of Prostate-Specific Membrane Antigen-Radioligand Uptake on PET with Systemic Therapy in Patients with Metastatic Renal Cell Carcinoma. Cancers. 2025; 17(11):1736.
https://doi.org/10.3390/cancers17111736
Chicago/Turabian Style
Kunte, Sophie Carina, Adrien Holzgreve, Marcus Unterrainer, Josef Zahner, Hans Peter Schmid, Magdalena Schöll, Iulia Blajan, Gabriel T. Sheikh, Dirk Mehrens, Jozefina Casuscelli,
and et al. 2025. "Changes of Prostate-Specific Membrane Antigen-Radioligand Uptake on PET with Systemic Therapy in Patients with Metastatic Renal Cell Carcinoma" Cancers 17, no. 11: 1736.
https://doi.org/10.3390/cancers17111736
APA Style
Kunte, S. C., Holzgreve, A., Unterrainer, M., Zahner, J., Schmid, H. P., Schöll, M., Blajan, I., Sheikh, G. T., Mehrens, D., Casuscelli, J., Tamalunas, A. J., Werner, R. A., Stief, C. G., Staehler, M., & Unterrainer, L. M.
(2025). Changes of Prostate-Specific Membrane Antigen-Radioligand Uptake on PET with Systemic Therapy in Patients with Metastatic Renal Cell Carcinoma. Cancers, 17(11), 1736.
https://doi.org/10.3390/cancers17111736
